Trial intelligence / Profile preview

Topical Vaginal Estrogen for Postpartum OASIS Recovery

NCT05317364Phase 4Terminated

Sponsor
University of Alabama at Birmingham
Start
Jul 2022
Primary completion
Feb 2026
Countries
1
01

Overview

A Phase 4 trial of estradiol topical in obstetric anal sphincter injury (OASI), sexual dysfunction, fecal incontinence (FI), urinary incontinence (UI), sponsored by University of Alabama at Birmingham. Started Jul 2022; status: terminated.

02

Drugs

estradiol topical
03

Conditions

obstetric anal sphincter injury (OASI)sexual dysfunctionfecal incontinence (FI)urinary incontinence (UI)

Beyond the preview

Go deeper on NCT05317364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05317364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call